Nirmatrelvir with ritonavir

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Nirmatrelvir with ritonavir and local guidelines before prescribing.

Antiviral (protease inhibitor)

Mechanism

SARS-CoV-2 main protease inhibitor boosted by ritonavir.

Uses

COVID-19 in people at risk of severe disease.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Taste disturbance, diarrhoea, nausea, hypertension, myalgia.

Interactions

Many ritonavir CYP3A4 interactions: statins, anticoagulants, antiarrhythmics, colchicine, immunosuppressants.

Contraindications and cautions

Severe liver or renal impairment, interacting drugs

Monitoring

Interaction check

Pregnancy and breastfeeding

Avoid unless essential

Renal and hepatic impairment

Avoid in severe renal or hepatic impairment

Overdose and reversal

Supportive

Special advice

Review all medicines before prescribing; start within 5 days of symptom onset.

More from the textbook: uses, cautions and other points
Where it is discussed in the book